We pull your operational, financial, and patient data into one view, score five pillars against peer benchmarks, and turn each finding into a quantified action. Then we run it again every quarter — so you always know where the next dollar of margin lives.
| Order | Items | Belen Paid | Moxie Price | Savings | % |
|---|---|---|---|---|---|
| 04/10/2026 | Restylane-L · Dysport 300 | $19,080 | $17,143 | $1,937 | 10.2% |
| 03/25/2026 | Restylane-L · Sculptra | $8,302 | $7,194 | $1,108 | 13.3% |
| 05/12/2025 | 7 Restylane variants · Dysport · Sculptra | $57,836 | $48,574 | $9,262 | 16.0% |
| Across observed orders | $85,218 | $72,911 | $12,307 | 14.4% | |
| Provider | Rev (Dec) | Appts | Rev/Appt | Util. | Rebook | Rev/Hr | Strength |
|---|---|---|---|---|---|---|---|
| Provider A | $72K | 58 | $1,241 | 48% | 48% | $758 | Highest AOV |
| Provider B | $52K | 82 | $634 | 65% | 45% | $400 | Best utilization |
| Provider C | $38K | 65 | $585 | 58% | 35% | $317 | Device training opp |
| Provider D | $31K | 95 | $326 | 68% | 38% | $221 | Highest volume |
| Total | $193K | 300 | $643 | 58% | 42% | $398 |
Provider A's $758/hr shows exceptional clinical value — but at 48% utilization, half their capacity goes unused. Provider B at 65% utilization is actually the best-leveraged asset. Provider C has plateau'd at ~20% share for 6 months — device certification + $45K target = +$10K/mo.
| Lever | Monthly | Annual | Assumption |
|---|---|---|---|
| Rebook checkout 42% → 70% | +$14,280 | +$171K | 84 rebooks × $170 avg |
| Show rate 82% → 92% | +$8,400 | +$101K | 30 recovered appts × $280 |
| Reduce discounts 29% → 24% | +$8,500 | +$102K | 5pp on $3.14M gross |
| Retail ratio 5% → 12% | +$13,000 | +$156K | Staff training, checkout upsell |
| Launch Google Ads | +$6,500 | +$78K | 13 net new patients × $500 first-visit |
| Membership to 75 members | +$7,400 | +$89K | 37 net new × $200/mo MRR |
| Win-back 320 lapsed patients | +$4,800 | +$58K | 16 reactivated × $300 |
| Provider C ramp → $45K/mo | +$10,000 | +$120K | Device certification + targets |
| COGS stabilize 28% → 25% | +$5,550 | +$67K | Supply budget + tracking |
| Add provider #5 (NP, 60% utilization) | +$42,000 | +$504K | $70K capacity × 60% |
| Total Addressable | +$120K | +$1.45M | Run-rate $305K/mo → $3.67M annualized |
| What you need | Moxie delivers |
|---|---|
| "Day in a Glance" reporting | Moxie EMR + embedded reports |
| Better systems for scaling | Moxie Playbooks — SOPs, role maps, scaling templates |
| Automated reporting & KPI dashboards | Native to the Moxie EMR — we have it |
| Integrated payroll | Moxie Payroll + commission engine |
| Better Galderma pricing | $12K saved on 3 orders · ~$80–120K / year projected |
| Marketing tools when you're ready | Moxie Marketing Services — campaigns, attribution, ROI |
| Operational support | Standing Practice Success Manager · quarterly P360 |